Taipei Heart Institute (THI), Taipei Medical University

Medicine & Life Sciences

1. Atrial Fibrillation 100%
2. Pulmonary Veins 92%
3. Cardiac Myocytes 65%
4. Taiwan 50%
5. Heart Failure 43%
6. Calcium 42%
7. Endothelin-1 34%
8. Endothelial Cells 34%
9. Coronary Vessels 32%
10. Cardiac Arrhythmias 30%
11. trilinolein 29%
12. Blood Pressure 29%
13. Heart Atria 28%
14. Endothelial Progenitor Cells 27%
15. Catheter Ablation 27%
16. Reactive Oxygen Species 27%
17. Myocardial Infarction 26%
18. Population 25%
19. Cohort Studies 24%
20. Hypertension 24%
21. Angiotensin II 23%
22. Therapeutics 22%
23. Antioxidants 22%
24. Heart 21%
25. Action Potentials 21%
26. Nicorandil 21%
27. Cardiovascular Diseases 21%
28. Coronary Artery Disease 20%
29. Smooth Muscle Myocytes 20%
30. Inflammation 19%
31. Rabbits 19%
32. Hydroxymethylglutaryl-CoA Reductase Inhibitors 19%
33. Oxidative Stress 18%
34. Fibroblasts 18%
35. Hypertrophy 17%
36. Homeostasis 17%
37. Mortality 17%
38. Peroxisome Proliferator-Activated Receptors 16%
39. Pravastatin 16%
40. Electrocardiography 16%
41. Proteins 16%
42. Stroke 16%
43. Kidney 15%
44. Sinoatrial Node 15%
45. Elderly 15%
46. Histone Deacetylases 15%
47. Muscle Cells 15%
48. stevioside 15%
49. Gene Expression 15%
50. Superoxide Dismutase 15%
51. Down-Regulation 15%
52. Human Umbilical Vein Endothelial Cells 15%
53. Electrophysiology 15%
54. Nitric Oxide 14%
55. Inbred SHR Rats 14%
56. KATP Channels 14%
57. Infarction 14%
58. Phosphorylation 14%
59. Atrial Remodeling 14%
60. Atherosclerosis 14%
61. Apoptosis 14%
62. Blood Vessels 14%
63. Extracellular Signal-Regulated MAP Kinases 13%
64. urotensin II 13%
65. Heme Oxygenase-1 13%
66. Vaccination 13%
67. Glyburide 13%
68. Confidence Intervals 12%
69. Human Influenza 12%
70. Diabetes Mellitus 12%
71. Lipids 12%
72. Ventricular Remodeling 12%
73. Sitagliptin Phosphate 12%
74. Chronic Renal Insufficiency 12%
75. Neoplasms 12%
76. tanshinone 12%
77. Cardiology 12%
78. Chronic Obstructive Pulmonary Disease 11%
79. Fibrosis 11%
80. C-Reactive Protein 11%
81. Antihypertensive Agents 11%
82. Nitric Oxide Synthase Type III 11%
83. Incidence 11%
84. p38 Mitogen-Activated Protein Kinases 11%
85. oxidized low density lipoprotein 11%
86. Thrombomodulin 11%
87. Pharmaceutical Preparations 11%
88. Toll-Like Receptor 4 11%
89. Glucose 11%
90. Hospitalization 11%
91. Dipeptidyl-Peptidase IV Inhibitors 11%
92. Western Blotting 11%
93. Type 2 Diabetes Mellitus 11%
94. Messenger RNA 11%
95. Exercise 10%
96. Monocytes 10%
97. Tumor Necrosis Factor-alpha 10%
98. Macrophages 10%
99. In Vitro Techniques 10%
100. Collagen 10%